Table 2.
Characteristics | Patients (n = 380) |
---|---|
Age | |
Median—years | 18.0 (17.0–35.0) |
3–14 | 26 (6.8) |
15–49 | 299 (78.7) |
50–64 | 35 (9.2) |
≥65 | 20 (5.3) |
Female sex | 219 (57.6) |
Occupation | |
Student | 247 (65.0) |
Agricultural worker | 95 (25.0) |
Teacher or employee | 31 (8.2) |
Child | 7 (1.8) |
Smoking history | 10 (2.6) |
Alcohol drinking history | 5 (1.3) |
Coexisting disorder (condition) | |
Any | 45 (11.8) |
Hypertension | 15 (3.9) |
Diabetes | 5 (1.3) |
Hepatitis B infection† | 5 (1.3) |
Coronary heart disease | 4 (1.1) |
Thyroid disease | 3 (0.8) |
Cerebrovascular disease | 3 (0.8) |
Cancer (resected) | 2 (0.5) |
Hepatitis C infection‡ | 1 (0.3) |
Chronic bronchitis | 1 (0.3) |
Bronchiectasis | 1 (0.3) |
Epilepsia | 1 (0.3) |
Anaphylactoid purpura | 1 (0.3) |
Pregnancy | 1 (0.3) |
Hearing loss | 1 (0.3) |
Arthritis | 1 (0.3) |
Mania | 1 (0.3) |
Down’s syndrome | 1 (0.3) |
Myasthenia gravis | 1 (0.3) |
Urticaria | 1 (0.3) |
Renal calculus | 1 (0.3) |
Data are presented as the median (interquartile range) or n (%).
The presence of hepatitis B infection was defined as a positive result for hepatitis B surface antigen with or without elevated levels of alanine or aspartate aminotransferase.
The presence of hepatitis C infection was defined as a positive result for anti-hepatitis C virus (HCV) antibody; this patient refused to test for the HCV RNA level.